Evaluation of variables in illicit drug use: Does a controlled substance abuse screening tool identify illicit drug use?

Pain Physician

Volumn 7, Issue 1, 2004, Pages 71-75

  Manchikanti, Laxmiah ^a   Pampati, Vidyasagar ^a   Damron, Kim S ^a   McManus, Carla D ^a  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

Author keywords

Controlled substance abuse; Drug dependence; Illicit drug use; Substance abuse assessment

Indexed keywords

ILLICIT DRUG; OPIATE;

ACCURACY; ADULT; ARTICLE; BEHAVIOR DISORDER; CASE CONTROL STUDY; CHRONIC PAIN; CONTROLLED STUDY; DENIAL; DRUG CONTROL; DRUG DEPENDENCE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OPIATE ADDICTION; PATIENT SELECTION; PREDICTION; RETROSPECTIVE STUDY; SCREENING TEST; SUBSTANCE ABUSE; URINALYSIS; VALIDATION PROCESS;

EID: 1042269444     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Manchikanti L, Pampati V, Damron K et al. Prevalence of illicit drug use in patients without controlled substance abuse in interventional pain management. Pain Physician 2003; 6:173-178.
2. Lewin ICF. Analysis of Prescription Monitoring Programs. Prepared for Hoffman-LaRoche by Lewin ICF. Washington DC, April 26, 1991.
3. Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992; 8: 77-85.
4. Manchikanti L, Pampati V, Damron K et al. Prevalence of opioid abuse in interventional pain medicine practice settings: A randomized clinical evaluation. Pain Physician 2001; 4:358-365.
5. Manchikanti L, Pampati V, Damron K. Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J KY Med Assoc 2003; 101:329-335.
6. Manchikanti L, Beyer C, Damron K et al. A comparative evaluation of illicit drug use in patients with or without controlled substance abuse in interventional pain management. Pain Physician 2003; 6:281-286.
7. Polatin PB, Kinney RK, Gatchel RJ et al. Psychiatric illness and chronic low back pain: The mind and the spine - which goes first? Spine 1993; 18:66-71.
8. Chabal C, Erjavec MK, Jacobson L et al. Prescription opiate abuse in chronic pain patients: Clinical criteria, incidence, and predictors. Clin J Pain 1997; 13:150-155.
9. Atluri S, Boswell M, Hansen H et al. Guidelines for the use of controlled substances in the management of chronic pain. Pain Physician 2003; 6:233-257.
10. Fishman SM, Wilsey B, Yang J et al. Adherence monitoring and drug surveillance in chronic opioid therapy. J Pain Symptom Manage 2000; 20:293-307.
11. Sees KL, Clark W. Opioid use in the treatment of chronic pain: Assessment of addiction. J Pain Symptom Manage 1993; 8: 257-264.
12. Pancratz L, Hickman DH, Toth S. The identification and management of drug-seeking behavior in a medical center. Drug Alcohol Depend 1989; 24:115-118.
13. Atluri S, Sudarshan G. Evaluation of abnormal urine drug screens among patients with chronic non-malignant pain treated with opioids. Pain Physician 2003; 6:407-409.
14. Fishbain DA. Report on the prevalence of drug/alcohol abuse and dependence in chronic pain patients (CPPs). Subst Use Misuse 1996; 31:945-946.
15. Haller DL, Butler S. Use and abuse of prescription and recreational drugs by chronic pain patients. In Harris LS (ed). Problems of drug dependence, 1990. Washington DC: GPO, 1991: 456-457.
16. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Survey of Substance Abuse Treatment Services (N-SSATS): 2002. Data on Substance Abuse Treatment Facilities, DASIS Series: S-19, DHHS Publication No. (SMA) 03-3777, Rockville, MD, 2003.
17. American Medical Association. Curtailing prescription drug abuse while preserving therapeutic use: American Medical Association recommendations for drug control policy. In Wilford BB (ed). Balancing the Response to Prescription Drug Abuse. American Medical Association, Chicago, 1990, pp 273-298.
18. Manchikanti L, Singh V, Damron KS et al. Screening for controlled substance abuse in interventional pain management settings: Evaluation of an assessment tool. Pain Physician 2003; 6:425-434.
19. Atluri S, Sudarshan G. A screening tool to determine the risk of prescription opioid abuse among patients with chronic nonmalignant pain. Pain Physician 2002; 5: 447-448.
20. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: Report of 20 cases. J Pain Symptom Manage 1996; 11: 163-171
21. Coambs R, Jarry JL, Santhiapillai AC et al. The SISAP: A new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within general medical practice. Pain Res Manage 1996; 1:155-162.
22. Passik SD, Whitcomb L, Dodd S et al. Pain outcomes in long-term treatment with opioids: Preliminary results with a newly developed physician checklist. The fourth conference on pain management and chemical dependency. Washington, DC; 2000.
23. Katz NP, Sherburne S, Beach M et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg 2003; 97:1097-1102.
24. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998; 16:355-363
25. Portenoy RK. Opioid therapy for chronic non-malignant pain: Current status. In Fields HL, Liebeskind JC (eds). Progress in Pain Research and Management, Vol. 1. IASP Press, Seattle, 1994:247-287.
26. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: Evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 2003; 4: 182-185.
27. Weissman DE, Haddox JD. Opioid pseudo-addiction: An iatrogenic syndrome. Pain 1989; 36:363-366.